1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legislation

‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms

 
• By Hannah Daniel, Ryan Nelson, and Elizabeth Orr

Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.

US Capitol building on a cloudy day
• Source: Shutterstock

A stripped-down version of the US Food and Drug Administration user-fee reauthorization package, introduced in the Senate on 14 July, leaves out provisions for modernizing cosmetics oversight and strengthening dietary supplement regulations.

Sen. Richard Burr, R-NC, authored the FDA Simple Reauthorization Act as an antidote to the excessively amended FDA Safety...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

California Microbeads Legislation Moves Toward Passage As DTSC Proposes Restrictions

 
• By Lauren Nardella

Multiple microbeads measures in California could impact how manufacturers selling products in the state approach reformulation.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By Lauren Nardella

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 
• By Malcolm Spicer

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

More from Policy & Regulation

Washington State Urges Early Industry Input on Lead Rule to Avoid 1ppm Limit Fallback

 
• By Eileen Francis

The Washington Department of Ecology will begin collecting feedback for its rulemaking on lead limits for cosmetics under the Toxic Free Cosmetics Act early next year, and industry’s response throughout the process will be critical to determine the outcome.

US FDA Sets New Target Dates For MoCRA Rulemakings

 
• By Lauren Nardella

Updates to the US Food and Drug Administration's Unified Agenda reveal the agency plans to work on rules for talc, fragrance allergens and formaldehyde in the coming year, though a rulemaking for GMPs is no longer included in the agenda.

Shutdown Approaches: US FDA Would Retain Most Of Recently Trimmed Staff

 
• By Derrick Gingery

FDA shutdown plans indicate about 86% of staff would be retained, a rate that is higher than previous plans, but reserve funding would not last more than a few months.